# The INSPIRE Trial: A Study of Interferon Gamma-1b for Idiopathic Pulmonary Fibrosis (IPF)

> **NCT00075998** · PHASE3 · TERMINATED · sponsor: **InterMune** · enrollment: 826 (actual)

## Conditions studied

- Idiopathic Pulmonary Fibrosis
- Lung Disease
- Pulmonary Fibrosis

## Interventions

- **DRUG:** Interferon gamma-1b ("Actimmune")

## Key facts

- **NCT ID:** NCT00075998
- **Lead sponsor:** InterMune
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2003-12
- **Primary completion:** —
- **Final completion:** 2007-05
- **Target enrollment:** 826 (ACTUAL)
- **Why stopped:** test drug showed lack of benefit at interim analysis
- **Last updated:** 2009-07-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00075998

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00075998, "The INSPIRE Trial: A Study of Interferon Gamma-1b for Idiopathic Pulmonary Fibrosis (IPF)". Retrieved via MORVS 2026-10-12 from https://api.morvs.ai/clinical/NCT00075998. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*